FDA Clears Adjunctive Lung Ventilation Software for CT
With algorithms utilized in aerospace technology, the CT LVAS software reportedly provides enhanced assessment of regional airflow and lung ventilation.
The Food and Drug Administration (FDA) has granted 510(k) clearance for CT LVAS, an adjunctive software that provides detailed analysis of lung ventilation based on computed tomography (CT) scans.
Offering color-coded images of regional airflow and lung ventilation that are overlayed on CT scans, the CT LVAS provides quantifiable assessments of lung volume change and regional lung ventilation heterogeneity, according to 4DMedical, the developer of CT LVAS.
The company said the CT LVAS facilitates regional lung ventilation measurement in thousands of locations in the lungs.
“Having assisted with image interpretation of CT LVAS exams in Australia, I've seen the diagnostic power of adding functional assessment to the structural information provided in standard non-contrast chest CTs,” noted Greg Mogel, M.D., a consultant radiologist at 4DMedical. “CT LVAS allows radiologists to provide a whole new dimension of lung health information to referring clinicians needing answers.”
4DMedical added that the combination of CT LVAS with a forthcoming CT:VQ software, which provides quantitative perfusion assessment based on CT scans, may enhance the diagnosis of pulmonary embolism and assessment of conditions such as chronic obstructive pulmonary disease (COPD).
Recent Videos
Related Content
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025Article
In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025Article
In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025Article
In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
